Sunday, December 16, 2018 9:52:29 AM
HDFN has only about 8,000 cases, ~3,200 per year severe... What's up with that?
1. MNTA after working on this for years is confident that M281 will work good on this indication.
2. If proven safe and effective in this important trial... M281 will be the choice of drug in 'child bearing age' women that has MG or any autoimmune disease that M281 is good for, regardless if they have HDFN or not.
ie. if a woman wants to, or may get pregnant while she has MG or an autoimmune disease, she can confidently take M281 but not the other competing drugs because of this HDFN trial. And she does not have to have HDFN neither.
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM